Table 2.
The clinical characteristics of IBD patients and HCs.
| Characteristics | HC (N = 30) | A-CD (N = 30) | R-CD (N = 30) | A-UC (N = 30) | R-UC (N =3 0) | P-value |
|---|---|---|---|---|---|---|
| Age (years) | 36.7 (10.7) | 34.3 (9.6) | 36.0 (9.8) | 39.9 (12.1) | 37.9 (11.3) | 0.349 |
| Male/female | 14/16 | 17/13 | 11/19 | 16/14 | 14/16 | 0.586 |
| CRP (mg/L) | 2.9 (2.0–4.6) | 52.4 (36.1–68.9) | 17.4 (12.8–28.3) | 49.3 (37.9–77.0) | 19.8 (15.7–25/0) | <0.001 |
| ESR (mm/h) | 9.9 (7.9–13.4) | 47.5 (39.3–61.8) | 19.5 (13.1–29.3) | 44.3 (35.3–54.5) | 19.1 (12.7–22.3) | <0.001 |
| CDAI for CD | 242.0 (210.0–263.3) | 108.5 (91.3–139.3) | <0.001 | |||
| Mayo for UC | 6.0 (4.0–8.0) | 2.0 (1.0–2.0) | <0.001 |
Data were presented as mean (standard deviation), count or median (inter-quartile range). Difference was determined by one-way analysis of variance (ANOVA), Chi-square test, Wilcoxon rank sum test or Kruskal-Wallis H rank sum test. P < 0.05 was considered significant. IBD, inflammatory bowel disease; HC, healthy controls; A-CD, active Crohn's disease; R-CD, Crohn's disease with remission; A-UC, active ulcerative colitis; R-UC, ulcerative colitis with remission; CRP, C reactive protein; ESR, erythrocyte sedimentation rate; CDAI, Crohn's disease activity index.